The growing influence of practice guidelines has increased concern for potential sources of bias. Two recent guidelines for primary immune thrombocytopenia (ITP) provided a unique opportunity for a systematic comparison of different methods of practice guideline development. One guideline (International Consensus Report [ICR]) was supported by pharmaceutical companies that produce products for ...

T o avoid the necessity of relying on trust in the matter of scientific authorship, most biomedical journals have adopted the uniform requirements for manuscripts submitted to biomedical journals, which are produced by the International Committee of Medical Journal Editors (ICMJE). The scientific journals that are members of the ICMJE routinely ask contributors to sign a statement that they acc...

© 2017 Ancient Science of Life | Published by Wolters Kluwer Medknow Sir, There is a paucity of systematic documentation apropos the occurrence of adverse drug reactions (ADRs) and other safety issues of Ayurveda medicines. National Pharmacovigilance program (NPP) for Ayurvedic drugs is concerned with re‐evaluation of marketed drugs, risk management, promoting rational drug use, and crisis prep...

that we have adopted a disclosure policy for authors within the last year, following a related change in the policy of the British Association of Psychopharmacology (BAP) for members of Council. We are glad that we did. Disclosure is strongly preferable to concealment. When we drafted the BAP disclosure guidelines, we included conflicts of interest that might result from relationships to a volu...

A solution to get the problem off, have you found it? Really? What kind of solution do you resolve the problem? From what sources? Well, there are so many questions that we utter every day. No matter how you will get the solution, it will mean better. You can take the reference from some books. And the establishing a duty of care for pharmaceutical companies essays is one book that we really re...

obtained through CRS model is 0.868, indicating scope for lots of improvement for the Pharmaceutical companies k ey words: Volume 5• Number 1 • January June 2012

This article aims to evaluate the use of lean manufacturing practices, according to SAE J4000, in a supply chain of the pharmaceutical industry. The data were collected in four companies: a manufacturer, a distributor and two suppliers. The results show companies are aligned in only one of the six elements of the standard.

To test if this was true, Medius undertook a ‘snapshot’ survey in the last two months amongst 10 biotech companies, 6 multinational pharmaceutical companies and 5 investor groups. The survey was undertaken using a questionnaire and telephone interviews. The objective of the survey was to discover if behaviour amongst investors, biotech and pharma companies had changed in the past two years and,...

background: formaldehyde is one of the most serious air contaminant that can be found everywhere. some of the source of formaldehyde include product of building materials, decorated materials, cigarette smoke, etc. aldehydes compounds especially formaldehyde are used as disinfectants for sterilization in different industries. in this study we measured formaldehyde workplace exposure with niosh ...